NCT01433393View on ClinicalTrials.gov

Double-blind Comparative Study of TAK-875

PHASE3CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

Not specified

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Diabetes Mellitus
Interventions
DRUG

TAK-875

DRUG

TAK-875

DRUG

Placebo

Trial Locations (19)

Unknown

Kisarazu-shi

Matsuyama

Fukuoka-shi Nishi-ku

Kasuga-shi

Naka

Tsuchiura-shi

Takamatsu

Kyoto-shi Fushimi-ku

Nagasaki

Kashihara-shi

Kashiwara-shi

Osaka-shi Tsurumi-ku

Sakai-shi Nishi-ku

Shimotsuke-shi

Chiyoda-ku

Itabashi-ku

Ōta-ku

Shinjuku-ku

Toshima-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01433393 - Double-blind Comparative Study of TAK-875 | Biotech Hunter | Biotech Hunter